✦ LIBER ✦

Pure Antiestrogens The Most Important Advance in the Endocrine Therapy of Breast Cancer since 1896?

✍ Scribed by R. I. NICHOLSON; J. M. W. GEE; S. BRYANT; A. B. FRANCIS; R. A. McCLELLAND; J. KNOWLDEN; A. E. WAKELING; C. K. OSBORNE

Book ID: 119872745
Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 751 KB
Volume: 784
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1996.tb16247.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Current Role of Endocrine Therapy in

The Current Role of Endocrine Therapy in Locally Advanced Breast Cancer to Improve Breast Conservation Rates

✍ Monnier, Sindy; Zakhireh, Jennifer; Esserman, Laura J. 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 302 KB

The role of mammography in the evaluatio

The role of mammography in the evaluation of advanced breast cancer treated by initial endocrine therapy

✍ P. Sauven; R. Grant; I. Burn 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Abstract Fifty-five patients with locally advanced breast cancer treated with initial endocrine therapy have been followed up for periods of between 6 and 64 months (median 17 months) with regular clinical and radiological examination. The aim of the study was to evaluate the role of mammography

Hormonal therapy in breast cancer and pr

Hormonal therapy in breast cancer and predominant visceral disease: effectiveness of the new oral aromatase inactivator, Aromasin® (exemestane), in advanced breast cancer patients having progressed on antiestrogens

✍ Tedeschi, M.; Kvinnsland, S.; Jones, S.E.; Kaufmann, M.; Polli, A.; Fowst, C.; M 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 153 KB

A phase II, randomized, blinded study of

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

✍ Stephen R. D. Johnston; Vladimir F. Semiglazov; George M. Manikhas; Dominique Sp 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 180 KB

An open randomised trial of second-line

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole

✍ J.S Tobias; A Howell 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 122 KB

An open randomised trial of second-line

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole

✍ C. Rose; O. Vtoraya; A. Pluzanska; N. Davidson; M. Gershanovich; R. Thomas; S. J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 213 KB